Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Head and Neck Cancer

Free Subscription 13.05.2019 1 Am J Gastroenterol 1 Am J Pathol 1 Ann Surg 1 BMC Cancer 4 Clin Nucl Med 1 Head Neck 1 Histopathology 1 Int J Pediatr Otorhinolaryngol 1 Int J Radiat Oncol Biol Phys 3 J Clin Endocrinol Metab 3 J Nucl Med 6 Laryngoscope 1 Oral Oncol 1 Otolaryngol Head Neck Surg 15 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. ZHAO H, Xu W, Wang Z
   Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
   Am J Gastroenterol. 2017;112:1493.
   PubMed     Text format    
   
   

   
   Am J Pathol

2. LI M, Wang L, Zhan Y, Zeng T, et al
   Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis.
   Am J Pathol. 2019 May 2. pii: S0002-9440(19)30004.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg

3. WEN J, Wang G, Xie X, Lin G, et al
   Prognostic Value of a Four-miRNA Signature in Patients with Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection.
   Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003369.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

4. LIAO LJ, Hsu WL, Lo WC, Cheng PW, et al
   Health-related quality of life and utility in head and neck cancer survivors.
   BMC Cancer. 2019;19:425.
   PubMed     Text format     Abstract available
   
   

   
   Clin Nucl Med

5. SEO M, Kim YS, Lee JC, Han MW, et al
   Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a): Reply.
   Clin Nucl Med. 2018 Mar 13. doi: 10.1097/RLU.0000000000002066.
   PubMed     Text format    
   
   
6. TULCHINSKY M
   Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
   Clin Nucl Med. 2018 Apr 30. doi: 10.1097/RLU.0000000000002050.
   PubMed     Text format    
   
   
7. PICCARDO A, Giovanella L
   Re: Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a).
   Clin Nucl Med. 2018 Feb 27. doi: 10.1097/RLU.0000000000002042.
   PubMed     Text format    
   
   
8. SEO M, Kim YS, Lee JC, Han MW, et al
   Low-Dose Radioactive Iodine Ablation Is Sufficient in Patients With Small Papillary Thyroid Cancer Having Minor Extrathyroidal Extension and Central Lymph Node Metastasis (T3 N1a): Reply.
   Clin Nucl Med. 2018 Mar 7. doi: 10.1097/RLU.0000000000002060.
   PubMed     Text format    
   
   

   
   Head Neck

9. JACOBI C, Gahleitner C, Bier H, Knopf A, et al
   Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout.
   Head Neck. 2019 May 9. doi: 10.1002/hed.25796.
   PubMed     Text format     Abstract available
   
   

   
   Histopathology

10. ASAHINA M, Saito T, Hayashi T, Fukumura Y, et al
    Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
    Histopathology. 2019;74:514-525.
    PubMed     Text format     Abstract available
    
    

    
    Int J Pediatr Otorhinolaryngol

11. DOMBROWSKI ND, Wolter NE, Irace AL, Cunningham MJ, et al
    Mucoepidermoid carcinoma of the head and neck in children.
    Int J Pediatr Otorhinolaryngol. 2019;120:93-99.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

12. HUANG XD, Li YC, Chen FP, Zheng WH, et al
    Evolution and Dosimetric Analysis of MRI-detected Brainstem Injury Following Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 May 7. pii: S0360-3016(19)30694.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Endocrinol Metab

13. KLUBO-GWIEZDZINSKA J, Wartofsky L
    Commentary on: "Gene Expression Classifier versus Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules".
    J Clin Endocrinol Metab. 2018 Jul 18. pii: 5055545. doi: 10.1210/jc.2018-01081.
    PubMed     Text format    
    
    
14. TURNBULL C, Loveday C, Izatt L, Ellard S, et al
    Response to Letter to the Editor regarding : "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer" from Andreas Machens and Henning Dralle.
    J Clin Endocrinol Metab. 2018 Jul 18. pii: 5055548. doi: 10.1210/jc.2018-01094.
    PubMed     Text format    
    
    
15. MACHENS A, Dralle H
    Letter to the Editor: "p.Val804Met, the most frequent pathogenic mutation in RET, confers a very low lifetime risk of medullary thyroid cancer".
    J Clin Endocrinol Metab. 2018 Jun 26. pii: 5043208. doi: 10.1210/jc.2018-00906.
    PubMed     Text format    
    
    

    
    J Nucl Med

16. TULCHINSKY M, Binse I, Campenni A, Dizdarevic S, et al
    Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy.
    J Nucl Med. 2018 Apr 13. pii: jnumed.118.211359. doi: 10.2967/jnumed.118.211359.
    PubMed     Text format    
    
    
17. TESSELAAR MH, Crezee T, Schuurmans I, Gerrits D, et al
    Digitalis-like compounds restore hNIS expression and iodide uptake capacity in anaplastic thyroid cancer.
    J Nucl Med. 2017 Dec 14. pii: jnumed.117.200675. doi: 10.2967/jnumed.117.200675.
    PubMed     Text format     Abstract available
    
    
18. PATTISON DA, Bozin M, Gorelik A, Hofman MS, et al
    18F-fluorodeoxyglycose-avid thyroid incidentalomas: the importance of contextual interpretation.
    J Nucl Med. 2017 Oct 12. pii: jnumed.117.198085. doi: 10.2967/jnumed.117.198085.
    PubMed     Text format     Abstract available
    
    

    
    Laryngoscope

19. FRANZESE C, Fogliata A, Franceschini D, Navarria P, et al
    Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients.
    Laryngoscope. 2019 May 7. doi: 10.1002/lary.28048.
    PubMed     Text format     Abstract available
    
    
20. SILVER N, Weber RS, Lozano M, Hessel A, et al
    Reducing patient wait times in a head and neck cancer outpatient clinic: A pilot study.
    Laryngoscope. 2019 May 9. doi: 10.1002/lary.28020.
    PubMed     Text format     Abstract available
    
    
21. HWANG V, Mendez E, Chow LQM, Futran ND, et al
    Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy.
    Laryngoscope. 2019 May 10. doi: 10.1002/lary.27902.
    PubMed     Text format     Abstract available
    
    
22. MANGANO J, Sherman J
    In Response to Altered Molecular Profile in Thyroid Cancers From Patients Affected by Three Mile Island Nuclear Accident.
    Laryngoscope. 2019;129:E51.
    PubMed     Text format    
    
    
23. KAMRAN SC, Qureshi MM, Truong MT
    In response to Letter to the Editor regarding: Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer.
    Laryngoscope. 2019;129:E88-E90.
    PubMed     Text format    
    
    
24. GUNDUZ M, Hotomi M
    Regarding Primary Surgery Versus Primary Radiation-Based Treatment for Locally Advanced Oropharyngeal Cancer.
    Laryngoscope. 2019;129:E87.
    PubMed     Text format    
    
    

    
    Oral Oncol

25. HARTMAN DJ, Ahmad FS, Ferris RL, Rimm DL, et al
    Corrigendum to "Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma" [Oral Oncol. 86 (2018) 278-287].
    Oral Oncol. 2019 Apr 30. pii: S1368-8375(19)30128.
    PubMed     Text format    
    
    

    
    Otolaryngol Head Neck Surg

26. HEUKELOM J, Navran A, Gouw ZAR, Tesselaar ME, et al
    Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis.
    Otolaryngol Head Neck Surg. 2019 May 7:194599819846073.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

27. OWEIDA AJ, Phan A, Vancourt B, Robin T, et al
    Hypofractionated radiotherapy is superior to conventional fractionation in an orthotopic model of anaplastic thyroid cancer.
    Thyroid. 2018 May 18. doi: 10.1089/thy.2017.0706.
    PubMed     Text format     Abstract available
    
    
28. CHUNG SR, Choi YJ, Suh CH, Kim HJ, et al
    Thyroid incidentalomas detected on 18F-FDG PET/CT: Malignant risk stratification and management plan.
    Thyroid. 2018 May 15. doi: 10.1089/thy.2017.0560.
    PubMed     Text format     Abstract available
    
    
29. VERBURG F, Maeder U, Giovanella L, Luster M, et al
    Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and I-131 ablation.
    Thyroid. 2018 Apr 18. doi: 10.1089/thy.2017.0352.
    PubMed     Text format     Abstract available
    
    
30. NABHAN F, Porter K, Lupo M, Randolph GW, et al
    Heterogeneity in PPV of RAS Mutations in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2018 Apr 18. doi: 10.1089/thy.2017.0635.
    PubMed     Text format     Abstract available
    
    
31. MAGNER JA
    High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?
    Thyroid. 2018 Apr 9. doi: 10.1089/thy.2018.0121.
    PubMed     Text format    
    
    
32. UCAL Y, Tokat F, Duren M, Ince U, et al
    Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of MALDI Mass Spectrometry Imaging.
    Thyroid. 2019 May 8. doi: 10.1089/thy.2018.0392.
    PubMed     Text format     Abstract available
    
    
33. HUANG Y, Yu S, Cao S, Yin Y, et al
    MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit B alpha expression.
    Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0665.
    PubMed     Text format     Abstract available
    
    
34. HUK D, Ashtekar A, Magner A, La Perle K, et al
    Deletion of Rap1b, but not Rap1a or Epac1, reduces PKA-mediated thyroid cancer.
    Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0528.
    PubMed     Text format     Abstract available
    
    
35. JEON M, Kim HK, Kim EH, Kim ES, et al
    Decreasing Disease-specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2018.0159.
    PubMed     Text format     Abstract available
    
    
36. SCHMIDT JENSEN J, Gronhoj C, Mirian C, Jensen DH, et al
    Incidence and survival of thyroid cancer in children, adolescents, and young adults in Denmark: a nation-wide study from 1980 to 2014.
    Thyroid. 2018 Jun 26. doi: 10.1089/thy.2018.0067.
    PubMed     Text format     Abstract available
    
    
37. VAN NOSTRAND D
    Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0048.
    PubMed     Text format     Abstract available
    
    
38. BECKHAM TH, Romesser PB, Groen AH, Sabol C, et al
    Intensity Modulated Radiation Therapy with or without Concurrent Chemotherapy in Non-Anaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0214.
    PubMed     Text format     Abstract available
    
    
39. GRANI G, Lamartina L, Biffoni M, Giacomelli L, et al
    Sonographically estimated risks of malignancy for thyroid nodules computed with five standard classification systems: changes over time and their relation to malignancy.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0178.
    PubMed     Text format     Abstract available
    
    
40. BORSON-CHAZOT F, Dantony E, Illouz F, Lopez J, et al
    Effect of Buparlisib, a pan-class I PI3K inhibitor, in refractory follicular and poorly differentiated thyroid cancer.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2017.0663.
    PubMed     Text format     Abstract available
    
    
41. SEMRAD TJ, Keegan T, Semrad AM, Brunson A, et al
    Predictors of Neck Reoperation and Mortality after Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Thyroid. 2018 Jun 21. doi: 10.1089/thy.2017.0483.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: